ICPO Foundation signed the contract with Nuclear Medicine Research Infrastructure (NuMeRI) to establish an ICPO Collaborating Center and expand patient access to a new era of effective cancer therapeutics in South Africa: Dr. Mike Sathekge, CEO & President of NuMeRI; Dr. Jan Rijn Zeevaart, General Research Manager, NuMeRI; Martin Reuter, CFO ICPO Foundation; Odile Jaume, CEO ICPO Foundation; Prof. Richard P. Baum, President of the ICPO Academy for Theranostics (f.l.t.r.)